For an effective anticancer therapy, it is desirable to ensure that the damage induced by small molecule compounds like Plk1 inhibitors is strong enough to drive tumor cells undergoing apoptosis otherwise a drug resistance phenotype will be provoked. Here, PLK1 is linked to neoplasm.